In conclusion, in patients with NDD-CKD, oral supplementation with liposomal iron allows a partial correction of transferrin saturation in half of patients treated for six months, with no significant effect on serum ferritin and hemoglobin levels. The gene discussed is TF; the disease is chronic kidney disease.